HK Stock MarketDetailed Quotes

01877 JUNSHI BIO

Watchlist
  • 13.220
  • +0.600+4.75%
Market Closed Nov 29 16:08 CST
13.03BMarket Cap-6521P/E (TTM)

JUNSHI BIO Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Turnover
28.87%1.27B
17.37%786.06M
49.24%380.8M
3.38%1.5B
-19.04%986.46M
-29.21%669.7M
-59.47%255.15M
-63.89%1.45B
-55.18%1.22B
-55.26%946.05M
Operating income
28.87%1.27B
17.37%786.06M
49.24%380.8M
3.38%1.5B
-19.04%986.46M
-29.21%669.7M
-59.47%255.15M
-63.89%1.45B
-55.18%1.22B
-55.26%946.05M
Cost of sales
----
26.94%-210.8M
----
-26.79%-667.29M
----
9.97%-288.51M
----
58.17%-526.28M
----
30.92%-320.47M
Operating expenses
3.42%-325.34M
26.94%-210.8M
-26.41%-108.09M
-26.79%-667.29M
21.17%-336.85M
9.97%-288.51M
48.07%-85.51M
58.17%-526.28M
43.03%-427.31M
30.92%-320.47M
Gross profit
45.60%945.86M
50.91%575.26M
60.76%272.71M
-9.92%835.26M
-17.88%649.61M
-39.07%381.19M
-63.51%169.64M
-66.49%927.21M
-59.81%791.07M
-62.10%625.58M
Selling expenses
-23.31%-683.63M
-14.59%-427.55M
-4.91%-191.59M
-17.98%-844.36M
-7.91%-554.41M
-21.39%-373.13M
-13.69%-182.62M
2.57%-715.7M
2.59%-513.77M
27.27%-307.39M
Administrative expenses
1.71%-353.24M
-4.39%-252.6M
-8.99%-123.31M
3.71%-556.81M
14.33%-359.4M
18.06%-241.97M
36.74%-113.14M
10.75%-578.27M
2.03%-419.52M
0.07%-295.29M
Research and development expenses
31.19%-874.27M
42.40%-546.38M
47.64%-276.29M
18.74%-1.94B
22.34%-1.27B
10.70%-948.6M
-3.28%-527.66M
-15.26%-2.38B
-15.01%-1.64B
-12.14%-1.06B
Profit from asset sales
2,047.14%12.89M
----
--23.72M
----
-98.14%600.42K
----
----
----
3,894.61%32.2M
----
Revaluation surplus
34.45%-30.05M
----
81.15%-1.15M
----
-174.26%-45.85M
----
---6.12M
----
-111.83%-16.72M
----
-Changes in the fair value of other assets
34.45%-30.05M
----
81.15%-1.15M
----
-174.26%-45.85M
----
---6.12M
----
-111.83%-16.72M
----
Impairment and provision
120.72%7.53M
1,028.34%10.42M
143.94%9.01M
-49,865.96%-23.48M
-96.69%-36.36M
-2,836.59%-1.12M
-624.93%-20.52M
-113.74%-47K
-33.83%-18.49M
-92.74%41K
-Other impairment is provision
120.72%7.53M
1,028.34%10.42M
143.94%9.01M
-49,865.96%-23.48M
-96.69%-36.36M
-2,836.59%-1.12M
-624.93%-20.52M
-113.74%-47K
-33.83%-18.49M
-92.74%41K
Special items of operating profit
621.45%30.46M
-84.30%8.58M
-105.13%-1.84M
-28.30%126.46M
-672.06%-5.84M
-47.17%54.65M
369.12%35.89M
-10.92%176.38M
-67.98%1.02M
-36.84%103.45M
Operating profit
41.21%-961.58M
44.00%-632.28M
54.58%-294.39M
6.77%-2.4B
8.48%-1.64B
-20.64%-1.13B
-68.61%-648.11M
-429.51%-2.57B
-530.57%-1.79B
-726.17%-935.86M
Financing cost
-113.62%-7.54M
-67.67%-24.39M
-89.58%1.55M
1.24%-29.01M
-22.42%55.34M
-6.20%-14.55M
129.95%14.89M
-34.52%-29.37M
1,500.36%71.34M
39.26%-13.7M
Share of profits of associates
----
36.04%-19.35M
----
20.19%-55.45M
----
-9.06%-30.25M
----
-43.27%-69.48M
----
-139.74%-27.74M
Share of profit from joint venture company
----
-331.60%-8.88M
----
-224.58%-5.03M
----
-300.19%-2.06M
----
-4,528.57%-1.55M
----
-51,300.00%-514K
Special items of earning before tax
42.83%-15.52M
----
12.32%-3.71M
----
-150.28%-27.15M
----
-126.16%-4.24M
----
54.31%-10.85M
30.60%-11.11M
Earning before tax
38.75%-984.64M
41.75%-684.89M
53.48%-296.55M
6.93%-2.49B
6.91%-1.61B
-18.90%-1.18B
-67.85%-637.45M
-351.40%-2.68B
-452.97%-1.73B
-1,095.63%-988.91M
Tax
-107.79%-4.08M
-107.03%-3.55M
-43.05%-3.1M
-147.25%-44M
782.01%52.39M
634.45%50.5M
94.77%-2.17M
168.70%93.11M
90.38%-7.68M
89.36%-9.45M
After-tax profit from continuing operations
36.42%-988.73M
38.82%-688.45M
53.15%-299.65M
1.87%-2.53B
10.34%-1.56B
-12.72%-1.13B
-51.86%-639.62M
-254.60%-2.58B
-342.34%-1.73B
-9,578.40%-998.36M
Earning after tax
36.42%-988.73M
38.82%-688.45M
53.15%-299.65M
1.87%-2.53B
10.34%-1.56B
-12.72%-1.13B
-51.86%-639.62M
-254.60%-2.58B
-342.34%-1.73B
-9,578.40%-998.36M
Minority profit
58.22%-61.96M
66.84%-42.75M
82.72%-16.62M
-28.68%-252.26M
-6.08%-148.31M
-48.13%-128.92M
-287.96%-96.19M
-1,936.87%-196.03M
-47,495,955.67%-139.81M
-8,703,000.00%-87.03M
Profit attributable to shareholders
34.12%-926.77M
35.20%-645.69M
47.92%-283.03M
4.38%-2.28B
11.78%-1.41B
-9.34%-996.42M
-37.09%-543.43M
-232.06%-2.39B
-306.69%-1.59B
-8,751.31%-911.33M
Basic earnings per share
34.27%-0.94
34.65%-0.66
47.27%-0.29
10.77%-2.32
18.29%-1.43
-1.00%-1.01
-25.00%-0.55
-225.00%-2.6
-297.73%-1.75
-10,100.00%-1
Diluted earnings per share
34.27%-0.94
34.65%-0.66
47.27%-0.29
10.77%-2.32
18.29%-1.43
-1.00%-1.01
-25.00%-0.55
-225.00%-2.6
-297.73%-1.75
-10,100.00%-1
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
Auditor
--
--
--
Huapu Tianjian Certified Public Accountants Co., Ltd. (Special General Partnership)
--
--
--
Huapu Tianjian Certified Public Accountants Co., Ltd. (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Turnover 28.87%1.27B17.37%786.06M49.24%380.8M3.38%1.5B-19.04%986.46M-29.21%669.7M-59.47%255.15M-63.89%1.45B-55.18%1.22B-55.26%946.05M
Operating income 28.87%1.27B17.37%786.06M49.24%380.8M3.38%1.5B-19.04%986.46M-29.21%669.7M-59.47%255.15M-63.89%1.45B-55.18%1.22B-55.26%946.05M
Cost of sales ----26.94%-210.8M-----26.79%-667.29M----9.97%-288.51M----58.17%-526.28M----30.92%-320.47M
Operating expenses 3.42%-325.34M26.94%-210.8M-26.41%-108.09M-26.79%-667.29M21.17%-336.85M9.97%-288.51M48.07%-85.51M58.17%-526.28M43.03%-427.31M30.92%-320.47M
Gross profit 45.60%945.86M50.91%575.26M60.76%272.71M-9.92%835.26M-17.88%649.61M-39.07%381.19M-63.51%169.64M-66.49%927.21M-59.81%791.07M-62.10%625.58M
Selling expenses -23.31%-683.63M-14.59%-427.55M-4.91%-191.59M-17.98%-844.36M-7.91%-554.41M-21.39%-373.13M-13.69%-182.62M2.57%-715.7M2.59%-513.77M27.27%-307.39M
Administrative expenses 1.71%-353.24M-4.39%-252.6M-8.99%-123.31M3.71%-556.81M14.33%-359.4M18.06%-241.97M36.74%-113.14M10.75%-578.27M2.03%-419.52M0.07%-295.29M
Research and development expenses 31.19%-874.27M42.40%-546.38M47.64%-276.29M18.74%-1.94B22.34%-1.27B10.70%-948.6M-3.28%-527.66M-15.26%-2.38B-15.01%-1.64B-12.14%-1.06B
Profit from asset sales 2,047.14%12.89M------23.72M-----98.14%600.42K------------3,894.61%32.2M----
Revaluation surplus 34.45%-30.05M----81.15%-1.15M-----174.26%-45.85M-------6.12M-----111.83%-16.72M----
-Changes in the fair value of other assets 34.45%-30.05M----81.15%-1.15M-----174.26%-45.85M-------6.12M-----111.83%-16.72M----
Impairment and provision 120.72%7.53M1,028.34%10.42M143.94%9.01M-49,865.96%-23.48M-96.69%-36.36M-2,836.59%-1.12M-624.93%-20.52M-113.74%-47K-33.83%-18.49M-92.74%41K
-Other impairment is provision 120.72%7.53M1,028.34%10.42M143.94%9.01M-49,865.96%-23.48M-96.69%-36.36M-2,836.59%-1.12M-624.93%-20.52M-113.74%-47K-33.83%-18.49M-92.74%41K
Special items of operating profit 621.45%30.46M-84.30%8.58M-105.13%-1.84M-28.30%126.46M-672.06%-5.84M-47.17%54.65M369.12%35.89M-10.92%176.38M-67.98%1.02M-36.84%103.45M
Operating profit 41.21%-961.58M44.00%-632.28M54.58%-294.39M6.77%-2.4B8.48%-1.64B-20.64%-1.13B-68.61%-648.11M-429.51%-2.57B-530.57%-1.79B-726.17%-935.86M
Financing cost -113.62%-7.54M-67.67%-24.39M-89.58%1.55M1.24%-29.01M-22.42%55.34M-6.20%-14.55M129.95%14.89M-34.52%-29.37M1,500.36%71.34M39.26%-13.7M
Share of profits of associates ----36.04%-19.35M----20.19%-55.45M-----9.06%-30.25M-----43.27%-69.48M-----139.74%-27.74M
Share of profit from joint venture company -----331.60%-8.88M-----224.58%-5.03M-----300.19%-2.06M-----4,528.57%-1.55M-----51,300.00%-514K
Special items of earning before tax 42.83%-15.52M----12.32%-3.71M-----150.28%-27.15M-----126.16%-4.24M----54.31%-10.85M30.60%-11.11M
Earning before tax 38.75%-984.64M41.75%-684.89M53.48%-296.55M6.93%-2.49B6.91%-1.61B-18.90%-1.18B-67.85%-637.45M-351.40%-2.68B-452.97%-1.73B-1,095.63%-988.91M
Tax -107.79%-4.08M-107.03%-3.55M-43.05%-3.1M-147.25%-44M782.01%52.39M634.45%50.5M94.77%-2.17M168.70%93.11M90.38%-7.68M89.36%-9.45M
After-tax profit from continuing operations 36.42%-988.73M38.82%-688.45M53.15%-299.65M1.87%-2.53B10.34%-1.56B-12.72%-1.13B-51.86%-639.62M-254.60%-2.58B-342.34%-1.73B-9,578.40%-998.36M
Earning after tax 36.42%-988.73M38.82%-688.45M53.15%-299.65M1.87%-2.53B10.34%-1.56B-12.72%-1.13B-51.86%-639.62M-254.60%-2.58B-342.34%-1.73B-9,578.40%-998.36M
Minority profit 58.22%-61.96M66.84%-42.75M82.72%-16.62M-28.68%-252.26M-6.08%-148.31M-48.13%-128.92M-287.96%-96.19M-1,936.87%-196.03M-47,495,955.67%-139.81M-8,703,000.00%-87.03M
Profit attributable to shareholders 34.12%-926.77M35.20%-645.69M47.92%-283.03M4.38%-2.28B11.78%-1.41B-9.34%-996.42M-37.09%-543.43M-232.06%-2.39B-306.69%-1.59B-8,751.31%-911.33M
Basic earnings per share 34.27%-0.9434.65%-0.6647.27%-0.2910.77%-2.3218.29%-1.43-1.00%-1.01-25.00%-0.55-225.00%-2.6-297.73%-1.75-10,100.00%-1
Diluted earnings per share 34.27%-0.9434.65%-0.6647.27%-0.2910.77%-2.3218.29%-1.43-1.00%-1.01-25.00%-0.55-225.00%-2.6-297.73%-1.75-10,100.00%-1
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IAS
Audit Opinions ------Unqualified Opinion------Unqualified Opinion----
Auditor ------Huapu Tianjian Certified Public Accountants Co., Ltd. (Special General Partnership)------Huapu Tianjian Certified Public Accountants Co., Ltd. (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data